Related Experiment Video
Updated: Aug 25, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II
B Lankat-Buttgereit1, C Gregel, A Knolle
1Clinical Research Unit for Gastrointestinal Endocrinology, University of Marburg, Baldingerstrasse, 35033 Marburg, Germany.
Abstract:
To identify new genes that are upregulated during apoptosis we previously cloned rat pdcd4. While the role of pdcd4 is still unclear it seems to possess a tumor suppressor activity. Pdcd4 directly interacts with the RNA helicase eIF4A and inhibits protein synthesis by interfering with the assembly of the cap-dependent translation initiation complex. In the present study, we show that pdcd4 suppresses carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells. Since tumor cells require a high bicarbonate flux for their growth, carbonic anhydrase suppression results in growth inhibition. Similar to pdcd4, carbonic anhydrase inhibitor ethoxyzolamide reduces growth of several endocrine tumor cell lines. Thus, the translation inhibitor pdcd4 represses endocrine tumor cell growth by suppression of carbonic anhydase II. Furthermore, carbonic anhydrase inhibitors might represent promising tools for anti-endocrine tumor treatment.
Insights
Programmed cell death 4 (pdcd4) suppresses endocrine tumor cell growth by inhibiting carbonic anhydrase II. Carbonic anhydrase inhibitors show promise for anti-endocrine tumor therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Programmed cell death 4 (pdcd4) is a newly identified gene upregulated during apoptosis.
- Pdcd4 exhibits tumor suppressor activity and interacts with eukaryotic initiation factor 4A (eIF4A) to inhibit protein synthesis.
- Tumor cell proliferation relies on high bicarbonate flux, which is regulated by carbonic anhydrase.
Purpose of the Study:
- To investigate the role of pdcd4 in regulating carbonic anhydrase II expression.
- To determine the effect of pdcd4-mediated carbonic anhydrase suppression on endocrine tumor cell growth.
- To evaluate the therapeutic potential of carbonic anhydrase inhibitors in endocrine tumors.
Main Methods:
- Cloning of rat pdcd4.
- Analysis of pdcd4's effect on carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells.
- Assessment of ethoxyzolamide's effect on endocrine tumor cell line growth.
Main Results:
- Pdcd4 was shown to suppress carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells.
- Suppression of carbonic anhydrase by pdcd4 led to growth inhibition of these tumor cells.
- The carbonic anhydrase inhibitor ethoxyzolamide demonstrated reduced growth in several endocrine tumor cell lines.
Conclusions:
- The translation inhibitor pdcd4 represses endocrine tumor cell growth through the suppression of carbonic anhydrase II.
- Carbonic anhydrase inhibitors may serve as a promising therapeutic strategy for endocrine tumors.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

